HCV

Product Description

The Biorex Diagnostics HCV Rapid Test Devices are rapid, instrument-free immunochromatographic assays designed for the qualitative detection of antibodies associated with Hepatitis C Virus infection in human whole blood, serum, or plasma. These tests provide fast and reliable screening to support early identification of infection, clinical monitoring, and blood donor safety programs in hospitals, clinics, laboratories, and point-of-care settings.

This device offers a convenient solution for healthcare professionals who require timely results without the need for specialised equipment. The simple, one-step procedure allows visual interpretation of results within minutes, making it suitable for routine diagnostic workflows, rapid screening initiatives, and field use in resource-limited environments. The assay’s high sensitivity and specificity ensure accurate detection, reducing the risk of false positives or negatives and supporting confidence in clinical decision-making.

Key Features

• Rapid immunochromatographic detection – qualitative results within minutes
• High sensitivity and specificity – reliable identification of HCV antibody-positive samples
• Versatile sample types – compatible with whole blood, serum, or plasma
• Instrument-free – ideal for point-of-care, clinic, or laboratory use
• Ready-to-use format – minimal preparation, clear visual interpretation, reduced handling errors

Benefits
Use of the HCV Rapid Test Devices enables early recognition of viral exposure, supporting prompt clinical evaluation, patient counselling, and follow-up testing. The rapid workflow and ease of use improve laboratory efficiency and reduce turnaround times, making it possible to screen large numbers of individuals effectively.

These devices are particularly valuable for blood donor screening, epidemiological surveys, and monitoring of high-risk populations. Their reliable performance helps healthcare providers make informed decisions regarding patient management, therapy monitoring, and preventive measures.

By combining speed, convenience, and diagnostic accuracy, the HCV Rapid Test Devices provide a cost-effective solution for healthcare facilities seeking dependable antibody detection tools. Their robust design ensures consistent results across different clinical and field settings, contributing to enhanced public health surveillance, safer blood transfusion practices, and improved patient outcomes.

Contact Us for more information.